- multidrug resistance inhibition
- multifocal breast cancer
- multimodality treatment
- multiple endocrine adenomatosis
- multiple endocrine neoplasia syndrome
- multiple endocrine neoplasia type 1 syndrome
- multiple hamartoma syndrome
- multiple myeloma
- multiple sclerosis
- multiplicity
- multitargeted receptor tyrosine kinase inhibitor ABT-869
- mung bean
- muramyl tripeptide phosphatidylethanolamine
- muscle wasting
- musculoskeletal
- music therapy
- mustine
- mutagen
- mutate
- mutation
- mutation carrier
- myalgia
- myasthenia gravis